BlackRock’s Crescent Biopharma, Inc. Common Stock CBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $97.7K | Sell |
6,051
-1,212
| -17% | -$19.6K | ﹤0.01% | 4776 |
|
|
2025
Q1 | $153K | Sell |
7,263
-23
| -0.3% | -$483 | ﹤0.01% | 4612 |
|
|
2024
Q4 | $181K | Buy |
7,286
+7
| +0.1% | +$174 | ﹤0.01% | 4585 |
|
|
2024
Q3 | $123K | Buy |
7,279
+47
| +0.6% | +$794 | ﹤0.01% | 4581 |
|
|
2024
Q2 | $204K | Sell |
7,232
-94
| -1% | -$2.65K | ﹤0.01% | 4493 |
|
|
2024
Q1 | $2.2M | Sell |
7,326
-24
| -0.3% | -$7.2K | ﹤0.01% | 3916 |
|
|
2023
Q4 | $1.73M | Buy |
7,350
+3
| +0% | +$708 | ﹤0.01% | 4016 |
|
|
2023
Q3 | $1.1M | Sell |
7,347
-492
| -6% | -$73.8K | ﹤0.01% | 4150 |
|
|
2023
Q2 | $1.36M | Buy |
7,839
+1,350
| +21% | +$235K | ﹤0.01% | 4122 |
|
|
2023
Q1 | $818K | Sell |
6,489
-1,098
| -14% | -$138K | ﹤0.01% | 4308 |
|
|
2022
Q4 | $2.3M | Sell |
7,587
-72
| -0.9% | -$21.8K | ﹤0.01% | 4002 |
|
|
2022
Q3 | $423K | Sell |
7,659
-24
| -0.3% | -$1.33K | ﹤0.01% | 4682 |
|
|
2022
Q2 | $459K | Sell |
7,683
-999
| -12% | -$59.7K | ﹤0.01% | 4709 |
|
|
2022
Q1 | $990K | Sell |
8,682
-47
| -0.5% | -$5.36K | ﹤0.01% | 4581 |
|
|
2021
Q4 | $1.26M | Sell |
8,729
-23
| -0.3% | -$3.31K | ﹤0.01% | 4521 |
|
|
2021
Q3 | $1.92M | Sell |
8,752
-109
| -1% | -$23.9K | ﹤0.01% | 4280 |
|
|
2021
Q2 | $2.06M | Sell |
8,861
-19,375
| -69% | -$4.5M | ﹤0.01% | 4189 |
|
|
2021
Q1 | $8.5M | Buy |
28,236
+2,071
| +8% | +$623K | ﹤0.01% | 3618 |
|
|
2020
Q4 | $9.84M | Sell |
26,165
-3,184
| -11% | -$1.2M | ﹤0.01% | 3302 |
|
|
2020
Q3 | $9.01M | Sell |
29,349
-384
| -1% | -$118K | ﹤0.01% | 3192 |
|
|
2020
Q2 | $11.2M | Buy |
29,733
+2,009
| +7% | +$755K | ﹤0.01% | 3058 |
|
|
2020
Q1 | $6.32M | Sell |
27,724
-561
| -2% | -$128K | ﹤0.01% | 3180 |
|
|
2019
Q4 | $15M | Sell |
28,285
-1,014
| -3% | -$536K | ﹤0.01% | 3003 |
|
|
2019
Q3 | $12.6M | Buy |
29,299
+652
| +2% | +$281K | ﹤0.01% | 3064 |
|
|
2019
Q2 | $34.1M | Sell |
28,647
-222
| -0.8% | -$265K | ﹤0.01% | 2525 |
|
|
2019
Q1 | $36M | Buy |
28,869
+420
| +1% | +$523K | ﹤0.01% | 2450 |
|
|
2018
Q4 | $26.9M | Sell |
28,449
-86
| -0.3% | -$81.4K | ﹤0.01% | 2559 |
|
|
2018
Q3 | $41.1M | Buy |
28,535
+503
| +2% | +$724K | ﹤0.01% | 2471 |
|
|
2018
Q2 | $45.2M | Buy |
28,032
+16,174
| +136% | +$26.1M | ﹤0.01% | 2399 |
|
|
2018
Q1 | $19.2M | Buy |
11,858
+1,939
| +20% | +$3.15M | ﹤0.01% | 2782 |
|
|
2017
Q4 | $16.7M | Buy |
9,919
+4,673
| +89% | +$7.85M | ﹤0.01% | 2850 |
|
|
2017
Q3 | $7.34M | Buy |
5,246
+398
| +8% | +$557K | ﹤0.01% | 3285 |
|
|
2017
Q2 | $5.41M | Sell |
4,848
-291
| -6% | -$325K | ﹤0.01% | 3408 |
|
|
2017
Q1 | $2.79M | Buy |
5,139
+5,134
| +102,680% | +$2.79M | ﹤0.01% | 3524 |
|
|
2016
Q4 | $3K | Hold |
5
| – | – | ﹤0.01% | 3522 |
|
|
2016
Q3 | $3K | Hold |
5
| – | – | ﹤0.01% | 3497 |
|
|
2016
Q2 | $3K | Buy |
+5
| New | +$3K | ﹤0.01% | 3541 |
|